Atlas Trials

Biocon Limited

13 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Biocon Limited

RecordFirmDate
Comparison of the Pharmacokinetic and Pharmacodynamic Properties of Biocon's Insulin R U-500 With Humulin® R U-500 (US Reference Product) in Healthy Subjects (NCT05413863)Biocon Limited2022-05-30
A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19 (NCT04605926)Biocon Limited2020-11-01
Evaluation of Pharmacokinetics , Safety, Tolerability and Pharmacodynamics of Biocon Insulin Tregopil (NCT04141423)Biocon Limited2019-10-28
Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis (NCT04128579)Biocon Limited2019-10-01
A Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD (NCT03763318)Biocon Limited2019-07-15
A Study of Itolizumab (EQ001) to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity in Uncontrolled Asthma (NCT04007198)Biocon Limited2019-06-20
Comparision of Pharmacokinetics(PK) and Pharmacodynamics(PD) of Biocon Insulin R and Humulin® R (NCT04022317)Biocon Limited2019-06-18
Comparision of Pharmacokinetic and Pharmacodynamic of Biocon Insulin N and Humulin® N (NCT04022304)Biocon Limited2019-06-15
Comparison of Pharmacokinetic (PK) and Pharmacodynamic(PD) of Biocon Insulin 70/30 and Humulin® 70/30 (NCT04022291)Biocon Limited2019-06-15

Track Biocon Limited automatically

Every clearance here is in the API, with alerts when new ones post.